Angel Pharmaceutical is an innovative pharmaceutical company focus on bringing medicines to patients with difficult to treat cancers and immune disorders. Angel Pharmaceuticals was formed and launched with investments 280 Million RMB in October 2021, financing by a Chinese investor group that includes funds associated with Betta Pharmaceuticals, Tigermed, Hisun Pharmaceuticals and Zhejiang Puissance Capital, and strategic collaboration with Corvus Pharmaceuticals (CRVS). With the mission of providing benefit to Chinese patients, Angel Pharmaceutical is committed to let Chinese cancer patients use the world's leading innovative medicine for the treatment of cancer, autoimmune diseases and other serious diseases.